Myung Ho Jeong Selected Research

Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)

7/2023	The impact of angiotensin-converting-enzyme inhibitors versus angiotensin receptor blockers on 3-year clinical outcomes in elderly (≥ 65) patients with acute myocardial infarction without hypertension.
1/2023	Impact of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers on clinical outcomes in hypertensive patients with acute myocardial infarction.
1/2023	Renin-Angiotensin-Aldosterone System Inhibitions and Cardiovascular Outcomes in Acute Myocardial Infarction With Renal Impairment.
1/2023	Angiotensin converting enzyme inhibitors versus angiotensin II type 1 receptor blockers in patients with acute myocardial infarction and prediabetes after successful implantation of newer-generation drug-eluting stents.
1/2022	Treatment delay and outcomes of ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention during the COVID-19 era in South Korea.
1/2021	Comparative effect of angiotensin converting enzyme inhibitor versus angiotensin ii type i receptor blocker in acute myocardial infarction with non-obstructive coronary arteries; from the Korea Acute Myocardial Infarction Registry - National Institute of Health.
1/2020	ACE Inhibitors Versus ARBs in Patients With NSTEMI With Preserved LV Systolic Function Who Underwent PCI With New Generation Drug-Eluting Stents.
1/2020	The impact of angiotensin-converting-enzyme inhibitors versus angiotensin receptor blockers on 3-year clinical outcomes in patients with acute myocardial infarction without hypertension.
1/2020	Comparison of clinical outcomes between angiotensin-converting-enzyme inhibitors and ARBs in patients with acute myocardial infarction with dyslipidemia after a successful stent implantation.
11/2019	Angiotensin Receptor Blockers as an Alternative to Angiotensin-Converting Enzyme Inhibitors in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Myung Ho Jeong Research Topics

Disease

361	Myocardial Infarction 05/2024 - 03/2003
181	Cardiovascular Diseases (Cardiovascular Disease) 02/2024 - 09/2003
138	Thrombosis (Thrombus) 05/2024 - 10/2004
122	ST Elevation Myocardial Infarction 01/2024 - 08/2007
89	Death (Near-Death Experience) 05/2024 - 09/2003
67	Acute Coronary Syndrome 02/2024 - 09/2003
55	Hemorrhage 12/2023 - 09/2003
48	Heart Failure 04/2024 - 10/2004
48	Non-ST Elevated Myocardial Infarction 04/2024 - 02/2005
42	Inflammation (Inflammations) 11/2023 - 06/2007
42	Hypertension (High Blood Pressure) 07/2023 - 01/2006
39	Coronary Artery Disease (Coronary Atherosclerosis) 10/2023 - 12/2004
35	Stroke (Strokes) 12/2023 - 01/2017
31	Hyperplasia 01/2024 - 07/2003
31	Diabetes Mellitus 09/2023 - 09/2003
30	Pathologic Constriction (Stenosis) 02/2023 - 12/2003
29	Infarction (Infarctions) 04/2024 - 08/2007
20	Chronic Renal Insufficiency 04/2024 - 11/2010
19	Cardiogenic Shock 04/2024 - 02/2005
19	Coronary Restenosis 10/2021 - 12/2004
18	Fibrosis (Cirrhosis) 12/2023 - 01/2006
18	Cardiomegaly (Heart Hypertrophy) 01/2023 - 01/2006
17	Depressive Disorder (Melancholia) 02/2024 - 01/2015
15	Left Ventricular Dysfunction 04/2024 - 10/2006
15	Prediabetic State (Prediabetes) 01/2023 - 01/2020
13	Type 2 Diabetes Mellitus (MODY) 04/2024 - 08/2014
12	Neoplasms (Cancer) 11/2022 - 10/2009
12	Neointima 01/2017 - 10/2007
11	No-Reflow Phenomenon 07/2016 - 10/2004
10	Dyslipidemias (Dyslipidemia) 12/2023 - 06/2012
10	Hypertrophy 01/2022 - 01/2006
10	Prolapse 01/2018 - 07/2008
8	Body Weight (Weight, Body) 01/2023 - 05/2014
8	Rupture 01/2021 - 07/2008
7	Ischemia 05/2024 - 06/2010
7	Anemia 03/2023 - 04/2012
7	Renal Insufficiency (Renal Failure) 05/2020 - 01/2011
7	Unstable Angina 01/2020 - 09/2003
6	Myocardial Ischemia (Ischemic Heart Diseases) 12/2023 - 12/2005
6	Spasm (Spasms) 01/2022 - 06/2006
6	Atrial Fibrillation 01/2021 - 10/2015
6	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2018 - 01/2011

Drug/Important Bio-Agent (IBA)

164	omega-Chloroacetophenone (Mace)IBA 04/2024 - 09/2003
61	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2024 - 12/2005
31	Clopidogrel (Plavix)FDA Link 12/2023 - 06/2008
27	C-Reactive ProteinIBA 02/2024 - 03/2003
25	PolymersIBA 11/2023 - 09/2009
24	Everolimus FDA Link 05/2024 - 09/2012
21	Angiotensin Receptor AntagonistsIBA 07/2023 - 06/2010
20	LDL CholesterolIBA 02/2024 - 10/2010
20	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 07/2023 - 04/2009
20	Sirolimus (Rapamycin)FDA Link 12/2022 - 06/2007
17	CreatinineIBA 03/2023 - 10/2007
17	zotarolimusIBA 01/2023 - 03/2010
16	TicagrelorIBA 12/2023 - 07/2016
15	Angiotensin IIIBA 01/2022 - 01/2006
15	MetalsIBA 01/2021 - 05/2009
14	Histone Deacetylases (Histone Deacetylase)IBA 01/2022 - 01/2006
13	Brain Natriuretic Peptide (Natrecor)FDA Link 04/2024 - 12/2005
13	FibrinIBA 11/2023 - 06/2006
13	Escitalopram FDA Link 01/2021 - 01/2015
13	Abciximab (ReoPro)FDA Link 06/2018 - 10/2004
12	Paclitaxel (Taxol)FDA LinkGeneric 05/2024 - 01/2011
12	oxidized low density lipoproteinIBA 02/2024 - 01/2011
12	Prasugrel Hydrochloride FDA Link 02/2023 - 02/2014
11	BESIBA 01/2023 - 11/2013
11	HDL CholesterolIBA 05/2020 - 04/2012
10	Biomarkers (Surrogate Marker)IBA 02/2024 - 01/2011
10	Isoproterenol (Isoprenaline)FDA LinkGeneric 12/2023 - 11/2008
10	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2023 - 06/2008
10	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2023 - 01/2017
10	Gallic AcidIBA 01/2022 - 11/2014
10	Indicators and Reagents (Reagents)IBA 01/2021 - 03/2005
9	Cilostazol (Pletal)FDA LinkGeneric 05/2024 - 01/2008
9	Histone Deacetylase InhibitorsIBA 01/2022 - 01/2006
9	Glycoproteins (Glycoprotein)IBA 01/2018 - 03/2005
9	Phenobarbital (Luminal)FDA Link 11/2016 - 09/2003
8	pro-brain natriuretic peptide (1-76)IBA 04/2024 - 12/2005
8	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 07/2014
8	Brain-Derived Neurotrophic Factor (BDNF)IBA 12/2022 - 12/2015
8	Hemoglobins (Hemoglobin)IBA 05/2022 - 03/2011
8	Rosuvastatin Calcium (Crestor)FDA Link 01/2021 - 06/2007
7	EnzymesIBA 01/2022 - 12/2005
7	CholesterolIBA 01/2022 - 10/2006
7	Heparin (Liquaemin)FDA LinkGeneric 10/2016 - 09/2003
6	MB Form Creatine KinaseIBA 02/2024 - 04/2011
6	LipidsIBA 12/2023 - 10/2007
6	Angiotensin II Type 1 Receptor BlockersIBA 07/2023 - 09/2013
6	Therapeutic UsesIBA 01/2023 - 01/2012
6	Triglycerides (Triacylglycerol)IBA 01/2021 - 01/2016
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2006
6	fimasartanIBA 09/2019 - 09/2013

Therapy/Procedure

267	Percutaneous Coronary Intervention 05/2024 - 03/2003
208	Stents 05/2024 - 07/2003
120	Drug-Eluting Stents 05/2024 - 10/2007
100	Therapeutics 11/2023 - 09/2003
31	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 05/2020 - 05/2003
9	Patient Readmission 01/2023 - 09/2015
7	Secondary Prevention 05/2022 - 02/2013
6	Extracorporeal Membrane Oxygenation 11/2023 - 06/2021